ROBIN HERCULSON: Open Payments
NPI 1578243358 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 96 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $5,362 · 2025 $2,262
Food & beverage: $2,177Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $367 |
| Ferring Pharmaceuticals Inc. | 19 | $265 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $210 |
| Sumitomo Pharma America, Inc. | 13 | $209 |
| PFIZER INC. | 9 | $163 |
| Endo USA, Inc. | 7 | $114 |
| Teleflex LLC | 1 | $114 |
| Valencia Technologies Corporation | 1 | $98 |
| SEAGEN INC. | 1 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
Products named: ADSTILADRIN, ERLEADA, Nubeqa, XTANDI, GEMTESA, RYBREVANT, AVEED, BARRIGEL.
Industry payments across MD — which companies pay providers there.
